Literature DB >> 15452687

Epsilon protein kinase C lengthens the quiescent period between spontaneous contractions in rat ventricular cardiac myocytes and trabecula.

Mourad Ogbi1, Christopher J Wingard, Safia Ogbi, John A Johnson.   

Abstract

We have observed a lengthening of the duration between spontaneous cardiac contractions under conditions that preferentially activate the epsilon protein kinase C (epsilonPKC) isozyme. Therefore, we investigated whether this response could be selectively mediated by epsilonPKC in neonatal cardiac myocytes (NCMs) and adult rat ventricular trabeculae. Contraction of NCMs was monitored using light scattering techniques and trabecular force generation was monitored in tissue baths using a force transducer. The involvement of the epsilonPKC isozyme was confirmed using an epsilonPKC-selective translocation inhibitor and Western blot translocation assays. In NCMs 3 nM 4-beta phorbol 12-myristate-13-acetate (PMA) treatment preferentially activates (translocates) epsilonPKC. In this study 3 nM 4-beta PMA induced a 2-fold increase in contractile amplitude and a approximately 14-fold increase in the quiescent period between contractions in NCMs. Extracellular adenosine 5'-triphosphate (ATP) also enhanced contractile amplitude by 1.7-fold and the quiescent period duration by 8-fold. The enhancement of quiescent period duration was attenuated by an epsilonPKC-selective translocation inhibitor. To investigate these relationships in intact myocardium, we studied spontaneously beating adult rat ventricular trabecula. In these fibers contractile amplitude was only modestly enhanced; however, the quiescent period was lengthened by 4.5-fold following a 15-min exposure to 3 nM 4-beta PMA. 4-beta PMA treatment also promoted arrhythmogenesis and increased the association of epsilonPKC with the particulate fraction in these fibers. Our results suggest that epsilonPKC may influence a specific phase of ventricular myocyte spontaneous beating. A better understanding of epsilonPKC modulation of spontaneous cardiac contraction may improve our understanding of the molecular events contributing to ventricular automaticity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15452687     DOI: 10.1007/s00210-004-0979-5

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  40 in total

1.  Evidence for functional role of epsilonPKC isozyme in the regulation of cardiac Ca(2+) channels.

Authors:  K Hu; D Mochly-Rosen; M Boutjdir
Journal:  Am J Physiol Heart Circ Physiol       Date:  2000-12       Impact factor: 4.733

2.  A protein kinase C translocation inhibitor as an isozyme-selective antagonist of cardiac function.

Authors:  J A Johnson; M O Gray; C H Chen; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1996-10-04       Impact factor: 5.157

Review 3.  The molecular heterogeneity of protein kinase C and its implications for cellular regulation.

Authors:  Y Nishizuka
Journal:  Nature       Date:  1988-08-25       Impact factor: 49.962

4.  Differential regulation of protein kinase C isoforms in isolated neonatal and adult rat cardiomyocytes.

Authors:  M Pucéat; R Hilal-Dandan; B Strulovici; L L Brunton; J H Brown
Journal:  J Biol Chem       Date:  1994-06-17       Impact factor: 5.157

5.  Localization of protein kinase C isozymes in cardiac myocytes.

Authors:  M H Disatnik; G Buraggi; D Mochly-Rosen
Journal:  Exp Cell Res       Date:  1994-02       Impact factor: 3.905

6.  A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death.

Authors:  M O Gray; J S Karliner; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1997-12-05       Impact factor: 5.157

7.  The epsilon subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation.

Authors:  B W Doble; P Ping; E Kardami
Journal:  Circ Res       Date:  2000-02-18       Impact factor: 17.367

8.  Ischemia-induced ventricular fibrillation in isolated perfused rat heart: role of alpha1A-adrenoceptor mediated activation of protein kinase C.

Authors:  R Tölg; J Schreieck; T Kurz; H A Katus; G Richardt
Journal:  Basic Res Cardiol       Date:  2001-02       Impact factor: 17.165

9.  Targeted disruption of the protein kinase C epsilon gene abolishes the infarct size reduction that follows ischaemic preconditioning of isolated buffer-perfused mouse hearts.

Authors:  Adrian T Saurin; Daniel J Pennington; Nicolaas J H Raat; David S Latchman; Michael J Owen; Michael S Marber
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

10.  C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo.

Authors:  D Ron; J Luo; D Mochly-Rosen
Journal:  J Biol Chem       Date:  1995-10-13       Impact factor: 5.157

View more
  1 in total

1.  Hypoxia-regulated activity of PKCepsilon in the lens.

Authors:  Vladimir Akoyev; Satyabrata Das; Snehalata Jena; Laura Grauer; Dolores J Takemoto
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-07       Impact factor: 4.799

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.